Literature DB >> 2915438

Decreased selenium levels in acute myocardial infarction.

F J Kok1, A Hofman, J C Witteman, A M de Bruijn, D H Kruyssen, M de Bruin, H A Valkenburg.   

Abstract

To study the association between selenium status and the risk of myocardial infarction, we compared plasma, erythrocyte, and toenail selenium levels and the activity of erythrocyte glutathione peroxidase among 84 patients with acute myocardial infarction and 84 population controls. Mean concentrations of all selenium measurements were lower in cases than controls. The differences were statistically significant, except for the plasma selenium level. A positive trend in the risk of acute myocardial infarction from high to low toenail selenium levels was observed, which persisted after adjustment for other risk factors for myocardial infarction. In contrast, erythrocyte glutathione peroxidase activity was significantly higher in cases than controls (31.3 +/- 8.4 U/g of hemoglobin and 28.0 +/- 8.1 U/g of hemoglobin, respectively). Because the toenail selenium level reflects blood levels up to one year before sampling, these findings suggest that a low selenium status was present before the infarction and, thus, may be of etiologic relevance. The higher glutathione peroxidase activity in the cases may be interpreted as a defense against increased oxidant stress either preceding or following the acute event.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2915438

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  18 in total

1.  Trends in mortality from coronary heart and cerebrovascular disease in Switzerland, 1969-87.

Authors:  C La Vecchia; F Levi; E Negri; A Randriamiharisoa; G Schüler; F Paccaud; F Gutzwiller
Journal:  Soz Praventivmed       Date:  1991

2.  Alterations in serum selenium levels and their relation to troponin I in acute myocardial infarction.

Authors:  Barbara Kutil; Petr Ostadal; Jiri Vejvoda; Jiri Kukacka; Jana Cepova; David Alan; Andreas Krüger; Dagmar Vondrakova
Journal:  Mol Cell Biochem       Date:  2010-08-01       Impact factor: 3.396

3.  Selenium and coronary heart disease: a meta-analysis.

Authors:  Gemma Flores-Mateo; Ana Navas-Acien; Roberto Pastor-Barriuso; Eliseo Guallar
Journal:  Am J Clin Nutr       Date:  2006-10       Impact factor: 7.045

Review 4.  Trace elements in nails as biomarkers in clinical research.

Authors:  Ka He
Journal:  Eur J Clin Invest       Date:  2010-08-31       Impact factor: 4.686

Review 5.  Selenium. Nutritional, toxicologic, and clinical aspects.

Authors:  A M Fan; K W Kizer
Journal:  West J Med       Date:  1990-08

6.  Selenium in serum as a possible parameter for assessment of breast disease.

Authors:  H Krsnjavi; D Beker
Journal:  Breast Cancer Res Treat       Date:  1990-07       Impact factor: 4.872

Review 7.  The pathophysiology and epidemiology of myocardial infarction. A review.

Authors:  J Gill
Journal:  Drugs       Date:  1991       Impact factor: 9.546

8.  Selenium status of Irish adults: evidence of insufficiency.

Authors:  J Murphy; K D Cashman
Journal:  Ir J Med Sci       Date:  2002 Apr-Jun       Impact factor: 1.568

9.  Serum selenium and prognosis in cardiovascular disease: results from the AtheroGene study.

Authors:  Edith Lubos; Christoph R Sinning; Renate B Schnabel; Philipp S Wild; Tanja Zeller; Hans J Rupprecht; Christoph Bickel; Karl J Lackner; Dirk Peetz; Joseph Loscalzo; Thomas Münzel; Stefan Blankenberg
Journal:  Atherosclerosis       Date:  2009-09-12       Impact factor: 5.162

10.  The impact of cardiopulmonary bypass on selenium status, thyroid function, and oxidative defense in children.

Authors:  R Holzer; B Bockenkamp; P Booker; P Newland; G Ciotti; M Pozzi
Journal:  Pediatr Cardiol       Date:  2004-05-12       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.